Skip to Content

Therapeutic Strategies During Cenobamate Treatment Initiation

This MEDtalk highlights Dr. Elinor Ben-Menachem’s expertise in epilepsy research, focusing on the newly approved anti-seizure medication cenobamate. With its dual mechanism of action, cenobamate shows potential as a highly effective treatment for focal-onset seizures, offering new hope for patients when carefully managed with existing therapies.

Elinor Ben-menachem

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top